Adding Capecitabine to Gemcitabine Improves OS in Resected Pancreatic Cancer
The addition of capecitabine to adjuvant gemcitabine following resection significantly improved overall survival.
All articles by Chris Bubeck
TP53, MDM2 Alterations Linked to Cisplatin Resistance in Testicular Cancer
TP53 and MDM2 alterations are associated with resistance to cisplatin and inferior progression-free survival among patients with metastatic germ cell tumors.
Assessing Mindfulness-based Cognitive Therapy For Cancer Pain
Researchers are attempting to determine the usefulness of mindfulness for cancer pain.
Poor Sleep Quality Associated With Symptom Burden Among Phase 1 Trial Participants
Patients who slept poorly exhibited greater symptom burden and overall mood disturbance.
ABCB1 Expression Associated With Response to Imatinib in Chronic Myeloid Leukemia
Increase in ABCB1 mRNA expression may serve as a marker for patients likely to be resistant to imatinib.
Inotuzumab Ozogamicin May Improve Survival for Patients With Acute Lymphoblastic Leukemia
Patients with ALL treated with the monoclonal antibody inotuzumab ozogamicin were more likely to proceed to stem cell transplantation.
New Method Helps Identify Neighborhood Factors Associated With Aggressive Prostate Cancer
Using a new methodology called a “neighborhood-wide association study,” researchers have identified 17 variables, out of more than 14,600, that were significantly associated with prostate cancer aggressiveness.
MicroRNA Down-regulate After Exposure to UV Radiation in Melanocytes of Women with a History of Melanoma
MicroRNAs in the melanocytes of women with a history of melanoma were down-regulated when exposed to ultraviolet radiation.
Multiple Myeloma May Be Linked to Pesticide Exposure
Exposure to the pesticides carbaryl, captan, and DDT is associated with increased risk for the development of myeloma in men.
Early Microwave Ablation Results Show Promise for Patients With T1a and T1b Renal Cell Carcinomas
Results from a small retrospective study showed that percutaneous microwave ablation (MWA) had a technical success rate higher than 95% for both T1a and T1b renal cell carcinomas.
- Loading...
Loading...
Next post in Renal Cell Carcinoma
Loading... 
Loading...